Several reports indicate that combining Chk1 inhibition and chemotherapy agents such as platinum, gemcitabine, pemetrexed, doxorubicin or radiotherapy has additive antitumor activity in different cancer types [10, 11]. The gene discussed is CHEK1; the disease is cancer.